{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T05:46:28Z","timestamp":1768715188830,"version":"3.49.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T00:00:00Z","timestamp":1646179200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T00:00:00Z","timestamp":1646179200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008375","name":"University of Basel","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008375","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>To assess the frequency and clinical characteristics of seizures in adult critically ill patients, to identify predictors of recurrent seizures not transforming into status epilepticus and\u00a0to characterize their effects on course and outcome.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>ICU patients at a Swiss academic medical center with seizures not transforming into status epilepticus from 2015 to 2020 were included. Recurrent seizures and associated clinical characteristics were primary, death, and return to premorbid neurologic function were secondary outcomes.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Two hundred of 26,370 patients (0.8%) with a median age of 65\u00a0years had seizures during ICU stay. Seizure semiology was described in 82% (49% generalized; 33% focal) with impaired consciousness during seizures in 80% and motor symptoms in 62%. Recurrent seizures were reported in 71% (36% on EEG) and associated with longer mechanical ventilation (<jats:italic>p<\/jats:italic>\u2009=\u20090.031), higher consultation rate by neurologists (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), and increased use of EEG (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) when compared to single seizures. The use of EEG was not associated with secondary outcomes. Acidosis at seizure onset and prior emergency operations were associated with decreased odds for seizure recurrence (OR 0.43; 95% CI 0.20\u20130.94 and OR 0.48; 95% CI 0.24\u20130.97). Epilepsy had increased odds for seizure recurrence (OR 3.56; 95% CI 1.14\u201311.16).\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Seizures in ICU patients are infrequent, but mostly recurrent, and associated with higher resource utilization. Whenever seizures are observed, clinicians should be vigilant about the increased risk of seizures recurrence and the need for antiseizure treatment must be carefully discussed. While known epilepsy seems to promote recurrent seizures, our results suggest that both acidosis and previous emergency surgery seem to have protective\/antiseizure effects.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>Clinicaltrials.gov (No. NCT03860467).<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00415-022-11038-6","type":"journal-article","created":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T14:02:40Z","timestamp":1646229760000},"page":"4185-4194","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Seizures and risks for recurrence in critically ill patients: an observational cohort study"],"prefix":"10.1007","volume":"269","clinical-trial-number":[{"clinical-trial-number":"nct03860467","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Anna S.","family":"Wagner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saskia","family":"Semmlack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anja","family":"Frei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5836-622X","authenticated-orcid":false,"given":"Stephan","family":"R\u00fcegg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4095-2765","authenticated-orcid":false,"given":"Stephan","family":"Marsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6575-356X","authenticated-orcid":false,"given":"Raoul","family":"Sutter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,2]]},"reference":[{"key":"11038_CR1","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1097\/CCM.0000000000004642","volume":"48","author":"SM Baumann","year":"2020","unstructured":"Baumann SM, Semmlack S, De Marchis GM, R\u00fcegg SH, Marsch S, Sutter R (2020) Frequency and implications of complications in the ICU after status epilepticus. No calm after the storm. Crit Care Med 48:1779\u20131789","journal-title":"Crit Care Med"},{"key":"11038_CR2","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373\u2013383","journal-title":"J Chronic Dis"},{"key":"11038_CR3","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/0196-6553(88)90053-3","volume":"16","author":"JS Garner","year":"1988","unstructured":"Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM (1988) CDC definitions for nosocomial infections, 1988. Am J Infect Control 16:128\u2013140","journal-title":"Am J Infect Control"},{"key":"11038_CR4","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/s12028-014-9967-x","volume":"21","author":"TE Gofton","year":"2014","unstructured":"Gofton TE, Chu MW, Norton L, Fox SA, Chase L, Murkin JM, Young GB (2014) A prospective observational study of seizures after cardiac surgery using continuous EEG monitoring. Neurocrit Care 21:220\u2013227","journal-title":"Neurocrit Care"},{"key":"11038_CR5","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1152\/jn.1990.63.2.225","volume":"63","author":"MM Haglund","year":"1990","unstructured":"Haglund MM, Schwartzkroin PA (1990) Role of Na-K pump potassium regulation and IPSPs in seizures and spreading depression in immature rabbit hippocampal slices. J Neurophysiol 63:225\u2013239","journal-title":"J Neurophysiol"},{"key":"11038_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/WNP.0000000000000806","volume":"38","author":"LJ Hirsch","year":"2021","unstructured":"Hirsch LJ, Fong MWK, Leitinger M, LaRoche SM, Beniczky S, Abend NS, Lee JW, Wusthoff CJ, Hahn CD, Westover MB, Gerard EE, Herman ST, Haider HA, Osman G, Rodriguez-Ruiz A, Maciel CB, Gilmore EJ, Fernandez A, Rosenthal ES, Claassen J, Husain AM, Yoo JY, So EL, Kaplan PW, Nuwer MR, van Putten M, Sutter R, Drislane FW, Trinka E, Gaspard N (2021) American clinical neurophysiology society\u2019s standardized critical care EEG terminology: 2021 version. J Clin Neurophysiol 38:1\u201329","journal-title":"J Clin Neurophysiol"},{"key":"11038_CR7","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1111\/j.1460-9568.2006.04665.x","volume":"23","author":"A Kirchner","year":"2006","unstructured":"Kirchner A, Veliskova J, Velisek L (2006) Differential effects of low glucose concentrations on seizures and epileptiform activity in vivo and in vitro. Eur J Neurosci 23:1512\u20131522","journal-title":"Eur J Neurosci"},{"key":"11038_CR8","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/nbm.1940060509","volume":"6","author":"O Kloiber","year":"1993","unstructured":"Kloiber O, Bockhorst K, Hoehn-Berlage M, Hossmann KA (1993) Effect of hypoxia on bicuculline seizures of rat: NMR spectroscopy and bioluminescence imaging. NMR Biomed 6:333\u2013338","journal-title":"NMR Biomed"},{"key":"11038_CR9","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1097\/00003246-198510000-00009","volume":"13","author":"WA Knaus","year":"1985","unstructured":"Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1985) APACHE II: a severity of disease classification system. Crit Care Med 13:818\u2013829","journal-title":"Crit Care Med"},{"key":"11038_CR10","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4103\/2319-4170.107152","volume":"36","author":"EH Kossoff","year":"2013","unstructured":"Kossoff EH, Wang HS (2013) Dietary therapies for epilepsy. Biomed J 36:2\u20138","journal-title":"Biomed J"},{"key":"11038_CR11","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1046\/j.1528-1157.2002.32601.x","volume":"43","author":"T Leniger","year":"2002","unstructured":"Leniger T, Wiemann M, Bingmann D, Widman G, Hufnagel A, Bonnet U (2002) Carbonic anhydrase inhibitor sulthiame reduces intracellular pH and epileptiform activity of hippocampal CA3 neurons. Epilepsia 43:469\u2013474","journal-title":"Epilepsia"},{"issue":"316","key":"11038_CR12","first-page":"e311","volume":"29","author":"LV Marcuse","year":"2014","unstructured":"Marcuse LV, Bronster DJ, Fields M, Polanco A, Yu T, Chikwe J (2014) Evaluating the obtunded patient after cardiac surgery: the role of continuous electroencephalography. J Crit Care 29(316):e311-315","journal-title":"J Crit Care"},{"key":"11038_CR13","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1097\/CCM.0b013e3181a00604","volume":"37","author":"M Oddo","year":"2009","unstructured":"Oddo M, Carrera E, Claassen J, Mayer SA, Hirsch LJ (2009) Continuous electroencephalography in the medical intensive care unit. Crit Care Med 37:2051\u20132056","journal-title":"Crit Care Med"},{"key":"11038_CR14","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1007\/s11064-021-03390-2","volume":"46","author":"HZ Ozsoy","year":"2021","unstructured":"Ozsoy HZ (2021) Anticonvulsant effects of carbonic anhydrase inhibitors: the enigmatic link between carbonic anhydrases and electrical activity of the brain. Neurochem Res 46:2783","journal-title":"Neurochem Res"},{"key":"11038_CR15","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1136\/jnnp.2005.080887","volume":"77","author":"AO Rossetti","year":"2006","unstructured":"Rossetti AO, Hurwitz S, Logroscino G, Bromfield EB (2006) Prognosis of status epilepticus: role of aetiology, age, and consciousness impairment at presentation. J Neurol Neurosurg Psychiatry 77:611\u2013615","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"11038_CR16","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1007\/s00415-016-8140-1","volume":"263","author":"S Semmlack","year":"2016","unstructured":"Semmlack S, Tschudin-Sutter S, Widmer AF, Valenca M, Ruegg S, Marsch S, Sutter R (2016) Independent impact of infections on the course and outcome of status epilepticus: a 10-year cohort study. J Neurol 263:1303\u20131313","journal-title":"J Neurol"},{"key":"11038_CR17","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.seizure.2019.10.009","volume":"73","author":"DC Silveira","year":"2019","unstructured":"Silveira DC, Sagi A, Romero R (2019) Are seizures predictors of mortality in critically ill patients in the intensive care unit (ICU)? Seizure 73:14\u201316","journal-title":"Seizure"},{"key":"11038_CR18","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/WNP.0000000000000216","volume":"33","author":"R Sutter","year":"2016","unstructured":"Sutter R (2016) Are we prepared to detect subtle and nonconvulsive status epilepticus in critically ill patients? J Clin Neurophysiol 33:25\u201331","journal-title":"J Clin Neurophysiol"},{"key":"11038_CR19","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1097\/CCM.0000000000002843","volume":"46","author":"R Sutter","year":"2018","unstructured":"Sutter R, Dittrich T, Semmlack S, Ruegg S, Marsch S, Kaplan PW (2018) Acute systemic complications of convulsive status epilepticus-a systematic review. Crit Care Med 46:138\u2013145","journal-title":"Crit Care Med"},{"key":"11038_CR20","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1212\/WNL.0000000000002023","volume":"85","author":"R Sutter","year":"2015","unstructured":"Sutter R, Ruegg S, Tschudin-Sutter S (2015) Seizures as adverse events of antibiotic drugs: a systematic review. Neurology 85:1332\u20131341","journal-title":"Neurology"},{"key":"11038_CR21","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/nrneurol.2016.45","volume":"12","author":"R Sutter","year":"2016","unstructured":"Sutter R, Semmlack S, Kaplan PW (2016) Nonconvulsive status epilepticus in adults\u2014insights into the invisible. Nat Rev Neurol 12:281\u2013293","journal-title":"Nat Rev Neurol"},{"key":"11038_CR22","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1111\/j.1528-1167.2012.03576.x","volume":"53","author":"R Sutter","year":"2012","unstructured":"Sutter R, Tschudin-Sutter S, Grize L, Fuhr P, Bonten MJ, Widmer AF, Marsch S, Ruegg S (2012) Associations between infections and clinical outcome parameters in status epilepticus: a retrospective 5-year cohort study. Epilepsia 53:1489\u20131497","journal-title":"Epilepsia"},{"key":"11038_CR23","doi-asserted-by":"publisher","first-page":"P306","DOI":"10.1186\/cc10913","volume":"16","author":"D Talwar","year":"2012","unstructured":"Talwar D, Nair V, Chudiwal J (2012) Seizures in the respiratory ICU: single-center study of patients with new-onset seizures. Crit Care 16:P306","journal-title":"Crit Care"},{"key":"11038_CR24","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/BF01709751","volume":"22","author":"JL Vincent","year":"1996","unstructured":"Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG (1996) The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction\/failure. On behalf of the working group on sepsis-related problems of the European society of intensive care medicine. Intensive Care Med 22:707\u2013710","journal-title":"Intensive Care Med"},{"key":"11038_CR25","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","volume":"370","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, Initiative S (2007) The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 370:1453\u20131457","journal-title":"Lancet"},{"key":"11038_CR26","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1126\/science.1059829","volume":"292","author":"K Yamada","year":"2001","unstructured":"Yamada K, Ji JJ, Yuan H, Miki T, Sato S, Horimoto N, Shimizu T, Seino S, Inagaki N (2001) Protective role of ATP-sensitive potassium channels in hypoxia-induced generalized seizure. Science 292:1543\u20131546","journal-title":"Science"},{"key":"11038_CR27","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/nn.2132","volume":"11","author":"AE Ziemann","year":"2008","unstructured":"Ziemann AE, Schnizler MK, Albert GW, Severson MA, Howard MA 3rd, Welsh MJ, Wemmie JA (2008) Seizure termination by acidosis depends on ASIC1a. Nat Neurosci 11:816\u2013822","journal-title":"Nat Neurosci"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-022-11038-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-022-11038-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-022-11038-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T16:27:30Z","timestamp":1658161650000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-022-11038-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,2]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["11038"],"URL":"https:\/\/doi.org\/10.1007\/s00415-022-11038-6","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,2]]},"assertion":[{"value":"14 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Anna S. Wagner reports no disclosures. Saskia Semmlack reports no disclosures. Anja Frei reports no disclosures. Stephan R\u00fcegg received unconditional research grants from UCB-pharma. He received honoraria from serving on the scientific advisory boards of Arvelle, Eisai, and UCB-pharma, and from serving as a consultant for Arvelle, Eisai, Pfizer, Novartis, Sandoz, and UCB-pharma. He does not hold any stocks of any pharmaceutical industries or manufacturers of medical devices. He received funding from UCB-pharma, and Swiss National Science Foundation Grants: Grant Number 320030_169379\/1 and coapplicant for grants numbers 33CM30_125115\/1 and 33CM30_140338\/1; he disclosed that he is the past-president of the Swiss League against Epilepsy (no payments), editor of EPILEPTOLOGIE (Journal of the Swiss League against Epilepsy) (no payments), and editor of the Swiss EEG Bulletin (payments from UCB); Stephan Marsch reports no disclosures. Raoul Sutter received research grants from the Swiss National Foundation (No 320030_169379), the Research Fund of the University Basel, the Scientific Society Basel, and the Gottfried Julia Bangerter-Rhyner Foundation. He received personal Grants from UCB-pharma and holds stocks from Novartis, Roche, Alcon, and Johnson & Johnson.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Prior to the initiation of the study the Swiss ethics committee (Ethikkommission Norwest- und Zentralschweiz approval number 2018-02361) approved the study concept in compliance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments and waived patients\u2019 consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}